This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Immunome, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovations of Danhui Zhang
Introduction: Danhui Zhang is an accomplished inventor based in San Carlos, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target tumor tissues. His work is pivotal in advancing cancer treatment methodologies.
Latest Patents: Danhui Zhang holds a patent for EphA2 antibodies. These antibodies are designed to bind preferentially to tumor tissue rather than normal tissue, specifically targeting EphA2. The applications of these antibodies include methods for inducing an immune response and inhibiting tumor cell growth. Additionally, he has provided methods for producing such antibodies, showcasing his innovative approach to cancer therapy.
Career Highlights: Danhui Zhang is currently employed at Immunome, Inc., where he continues to push the boundaries of medical research. His expertise in antibody development has positioned him as a key figure in the fight against cancer.
Collaborations: Danhui collaborates with notable colleagues, including Anne Ye and Michael Samuel Weiss. Their combined efforts contribute to the advancement of research in the field of immunology.
Conclusion: Danhui Zhang's work exemplifies the impact of innovative thinking in biotechnology. His contributions to the development of EphA2 antibodies represent a significant step forward in cancer treatment.